Clinical Trials Directory

Trials / Unknown

UnknownNCT02413086

Effectiveness and Safety of Early-Stage Amputation and External Herbs Chitosan for Diabetic Foot Ulcer

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
320 (estimated)
Sponsor
Heilongjiang University of Chinese Medicine · Academic / Other
Sex
All
Age
17 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Diabetic Foot as the popular chronic complications of diabetes, is one of the main factors leading to limb amputation, it was reported that the amputation rate is 15 times of the non-diabetic patients. Common surgical amputation is not only about high plane amputation but also bring a tremendous mental stress to patients which may affect the quality of life seriously. Diabetic foot patients facing the great risk of serious infection, endotoxemia , and septic shock which could be the main cause of death before amputation. It become an important topic that how to control the infection, reduce the amputation plane, save the function as possibility, and improve the life quality of the patients as well. This study is based on years of clinical experience of and brings out "early-stage amputation" concept firstly in China with a systematic exposition, experimental research and clinical research. Early-stage amputation refers to cut in the normal tissue from the inflammatory tissue at the junction line of limbs, in order to achieve more retained stump, block endotoxin absorption and improve the quality of life of patients. External therapy of herbs chitosan can promote granulation tissue regeneration and control of local infection, it solved the problem of difficult wound healing and it is a reliable guarantee of early-stage amputation.

Conditions

Interventions

TypeNameDescription
PROCEDUREEarly-stage amputationIndividuals with DFU were given early-stage amputation.
PROCEDUREAmputationIndividuals with DFU were given amputation.
OTHERExternal herbs chitosanWound was given external herbs chitosan after amputation.
OTHERTraditional gauzeWound was given traditional gauze after amputation.

Timeline

Start date
2015-04-01
Primary completion
2018-04-01
First posted
2015-04-09
Last updated
2015-04-09

Source: ClinicalTrials.gov record NCT02413086. Inclusion in this directory is not an endorsement.